Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Pretta

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Cancers|April 13, 2024
Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional ImagingGiuseppe Corrias, Eleonora Lai, Pina Ziranu, et al.
Cancer Medicine|June 6, 2023
The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinomaLetizia Procaccio, Valeria Merz, Morena Fasano, et al.
Scientific Reports|March 17, 2023
CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitorsPina Ziranu, Andrea Pretta, Marta Pozzari, et al.
Clinical Colorectal Cancer|August 18, 2021
Sex and Regorafenib Toxicity in Refractory Colorectal Cancer: Safety Analysis of the RegARd-C TrialCaroline Vandeputte, Giacomo Bregni, Paraskevas Gkolfakis, et al.
British Journal of Cancer|September 25, 2023
Mismatch Repair system protein deficiency as a resistance factor for locally advanced rectal adenocarcinoma patients receiving neoadjuvant chemo-radiotherapyAndrea Pretta, Pina Ziranu, Riccardo Giampieri, et al.
Clinical Colorectal Cancer|March 14, 2026
The Impact of Surgical Resection in Early Onset Colorectal Cancer Patients With Liver Limited DiseaseAndrea Pretta, Pina Ziranu, Francesca Bergamo, et al.
British Journal of Cancer|November 28, 2024
Early onset metastatic colorectal cancer patients as a distinctive clinical and molecular phenomenonAndrea Pretta, Pina Ziranu, Eleonora Perissinotto, et al.
Scientific Reports|November 6, 2022
Molecular profile and its clinical impact of IDH1 mutated versus IDH1 wild type intrahepatic cholangiocarcinomaMargherita Rimini, Carles Fabregat-Franco, Valentina Burgio, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 2022
Next-generation sequencing analysis of cholangiocarcinoma identifies distinct IDH1-mutated clustersMargherita Rimini, Eleonora Loi, Carles Fabregat-Franco, et al.
Acta Oncologica (Stockholm, Sweden)|July 22, 2022
Circulating DNA in the neoadjuvant setting of early stage colon cancerGiacomo Bregni, Andrea Pretta, Chiara Senti, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Cancers|April 13, 2024
Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional ImagingGiuseppe Corrias, Eleonora Lai, Pina Ziranu, et al.
Cancer Medicine|June 6, 2023
The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinomaLetizia Procaccio, Valeria Merz, Morena Fasano, et al.
Scientific Reports|March 17, 2023
CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitorsPina Ziranu, Andrea Pretta, Marta Pozzari, et al.
Clinical Colorectal Cancer|August 18, 2021
Sex and Regorafenib Toxicity in Refractory Colorectal Cancer: Safety Analysis of the RegARd-C TrialCaroline Vandeputte, Giacomo Bregni, Paraskevas Gkolfakis, et al.
British Journal of Cancer|September 25, 2023
Mismatch Repair system protein deficiency as a resistance factor for locally advanced rectal adenocarcinoma patients receiving neoadjuvant chemo-radiotherapyAndrea Pretta, Pina Ziranu, Riccardo Giampieri, et al.
Clinical Colorectal Cancer|March 14, 2026
The Impact of Surgical Resection in Early Onset Colorectal Cancer Patients With Liver Limited DiseaseAndrea Pretta, Pina Ziranu, Francesca Bergamo, et al.
British Journal of Cancer|November 28, 2024
Early onset metastatic colorectal cancer patients as a distinctive clinical and molecular phenomenonAndrea Pretta, Pina Ziranu, Eleonora Perissinotto, et al.
Scientific Reports|November 6, 2022
Molecular profile and its clinical impact of IDH1 mutated versus IDH1 wild type intrahepatic cholangiocarcinomaMargherita Rimini, Carles Fabregat-Franco, Valentina Burgio, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 2022
Next-generation sequencing analysis of cholangiocarcinoma identifies distinct IDH1-mutated clustersMargherita Rimini, Eleonora Loi, Carles Fabregat-Franco, et al.
Acta Oncologica (Stockholm, Sweden)|July 22, 2022
Circulating DNA in the neoadjuvant setting of early stage colon cancerGiacomo Bregni, Andrea Pretta, Chiara Senti, et al.
Pageof 6